A randomized simultaneous comparison of acceleromyography with a peripheral nerve stimulator for assessing reversal of rocuronium-induced neuromuscular blockade with sugammadex
Authors:
- Leon DrobnikLDLeon Drobnik
- Harald J SparrHSHarald J Sparr
- Sven-Egron ThörnSTSven-Egron Thörn
- Karin S Khuenl-BradyKKKarin S Khuenl-Brady
- Henk RietbergenHRHenk Rietbergen
- Martine E PrinsMPMartine E Prins
- Johan UllmanJUJohan Ullman
- 1 October 2010
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 27 (10) , 866-873
Abstract
We investigated the relationship between acceleromyography and a peripheral nerve stimulator for measuring reversal in patients administered sugammadex following rocuronium. In this randomized, active and within-participant controlled study, patients received rocuronium 0.6 mg kg for intubation with 0.15 mg kg maintenance doses as required. Single-dose sugammadex 4.0 or 1.0 mg kg was given 15 min after the last rocuronium dose. Neuromuscular monitoring was performed simultaneously: acceleromyography on one forearm and a peripheral nerve stimulator on the other. The peripheral nerve stimulator assessor was blinded to acceleromyography results. The primary efficacy end point was the difference between time from start of sugammadex 4.0 mg kg administration to recovery of the train-of-four ratio to 0.9 (acceleromyography) and time to reappearance of the fourth twitch (T4) (peripheral nerve stimulator). Sixty-one patients received sugammadex 4.0 mg kg. With acceleromyography, mean (SD) recovery time to a train-of-four ratio of at least 0.9 was 1.5 (0.7) min. With both the peripheral nerve stimulator and acceleromyography, mean (SD) time to T4 reappearance was 0.8 (0.3) min. Mean (95% confidence interval) difference between time to T4 reappearance (peripheral nerve stimulator) and recovery to a train-of-four ratio of at least 0.9 (acceleromyography) was 0.8 (0.6-0.9) min. T4 is detected at similar times when measured by a peripheral nerve stimulator or acceleromyography following sugammadex 4.0 mg kg administration 15 min after rocuronium. The mean interval between T4 reappearance (peripheral nerve stimulator) and recovery to a train-of-four ratio of at least 0.9 (acceleromyography) was 0.8 min. These findings provide guidance for evaluating the reversal effect of sugammadex in clinical situations.Keywords
This publication has 23 references indexed in Scilit:
- Residual Neuromuscular Blockade and Critical Respiratory Events in the Postanesthesia Care UnitAnesthesia & Analgesia, 2008
- Acceleromyography for Use in Scientific and Clinical PracticeAnesthesiology, 2008
- Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revisionActa Anaesthesiologica Scandinavica, 2007
- Brief review: Neuromuscular monitoring: an update for the clinicianCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2007
- Residual Paralysis at the Time of Tracheal ExtubationAnesthesia & Analgesia, 2005
- Accelerometry of Adductor Pollicis Muscle Predicts Recovery of Neuromuscular Blockade in Anesthetized PatientsAnesthesiology, 2003
- Evidence-based Practice and Neuromuscular MonitoringAnesthesiology, 2003
- Residual Paralysis in the PACU after a Single Intubating Dose of Nondepolarizing Muscle Relaxant with an Intermediate Duration of ActionAnesthesiology, 2003
- The Incidence and Mechanisms of Pharyngeal and Upper Esophageal Dysfunction in Partially Paralyzed HumansAnesthesiology, 2000
- Postoperative residual curarization and evidence-based anaesthesiaBritish Journal of Anaesthesia, 2000